Janssen-Cilag International withdraws application for Velcade (bortezomib) – Express Pharma
Janssen-Cilag International withdraws application for Velcade (bortezomib)Express PharmaJanssen-Cilag International NV on September 2, 2011, submitted an application to extend the marketing authorisation for Velcade in combination with rituximab for th…
